University Hospital Halle Saale

Halle 6120

4 studies enrolling now · 6 studies all time

What they study most

B-cell Non-Hodgkin Lymphoma (B-NHL), Crohn's Disease, Cytopenia, Focus: Long-term Retention of Gadolinium-based Contrast Agent, Inflammatory Bowel Diseases, MF, Myelodysplastic Syndromes, Myelofibrosis, Post-ET Myelofibrosis, Post-PV MF, Primary Myelofibrosis, Relapsed/Refractory Follicular Lymphoma

Studies at this site

• A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma — Recruiting now
• A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) — Recruiting now
• Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib — Recruiting now
• A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies — Running, not enrolling
• Long-Term Retention of Gadolinium in Bone — Completed